Alimentary Pharmacology & Therapeutics,
Journal Year:
2024,
Volume and Issue:
59(4), P. 585 - 586
Published: Jan. 21, 2024
LINKED
CONTENT
This
article
is
linked
to
Thomson
et
al
papers.
To
view
these
articles,
visit
https://doi.org/10.1111/apt.17823
and
https://doi.org/10.1111/apt.17842
MMWR Morbidity and Mortality Weekly Report,
Journal Year:
2024,
Volume and Issue:
73(8), P. 154 - 161
Published: Feb. 29, 2024
Deaths
from
causes
fully
attributable
to
alcohol
use
have
increased
during
the
past
2
decades
in
United
States,
particularly
2019
2020,
concurrent
with
onset
of
COVID-19
pandemic.However,
previous
studies
trends
not
assessed
underlying
deaths
that
are
partially
use,
such
as
injuries
or
certain
types
cancer.CDC's
Alcohol-Related
Disease
Impact
application
was
used
estimate
average
annual
number
and
agestandardized
rate
excessive
States
based
on
58
alcohol-related
death
three
periods
(2016-2017,
2018-2019,
2020-2021).Average
29.3%,
137,927
2016-2017
178,307
2020-2021;
age-standardized
rates
38.1
47.6
per
100,000
population.During
this
time,
among
males
26.8%,
94,362
year
119,606,
females
34.7%,
43,565
58,701.Implementation
evidence-based
policies
reduce
availability
accessibility
increase
its
price
(e.g.,
concentration
places
selling
taxes)
could
deaths.*
https://www.cdc.gov/nchs/products/databriefs/db448.htmalcohol
sales
†
also
time.Previous
included
(1,3),
cancer,
for
which
drinking
is
a
substantial
risk
factor
(4,5).A
comprehensive
assessment
changes
includes
conditions
can
guide
rationale
implementation
effective
prevention
strategies.
Methods
Annals of Internal Medicine,
Journal Year:
2024,
Volume and Issue:
177(5), P. 656 - 657
Published: April 22, 2024
Alcohol
is
used
by
more
people
in
the
United
States
than
tobacco,
electronic
nicotine
delivery
systems,
or
illicit
drugs.
Several
health
conditions,
including
cancer,
cardiovascular
disease,
and
liver
are
associated
with
excessive
alcohol
use
disorder.
Nearly
30
million
aged
12
years
older
reported
past-year
disorder
2022,
but-despite
its
prevalence-alcohol
undertreated.
In
this
policy
brief,
American
College
of
Physicians
outlines
effects
disorder,
calls
for
changes
to
increase
availability
treatment
use,
recommends
alcohol-related
public
interventions.
JAMA Health Forum,
Journal Year:
2024,
Volume and Issue:
5(4), P. e240501 - e240501
Published: April 12, 2024
Importance
Research
has
demonstrated
an
association
between
the
COVID-19
pandemic
and
increased
alcohol-related
liver
disease
hospitalizations
deaths.
However,
trends
in
complications
more
broadly
are
unclear,
especially
among
subgroups
disproportionately
affected
by
alcohol
use.
Objective
To
assess
people
with
high-acuity
admitted
to
emergency
department,
observation
unit,
or
hospital
during
pandemic,
focusing
on
demographic
differences.
Design,
Setting,
Participants
This
longitudinal
interrupted
time
series
cohort
study
analyzed
US
national
insurance
claims
data
using
Optum’s
deidentified
Clinformatics
Data
Mart
database
from
March
2017
September
2021,
before
after
2020
onset.
A
rolling
of
15
years
older
who
had
at
least
6
months
continuous
commercial
Medicare
Advantage
coverage
were
included.
Subgroups
interest
included
males
females
stratified
age
group.
April
2023
January
2024.
Exposure
environment
2021.
Main
Outcomes
Measures
Differences
monthly
rates
vs
predicted
complication
episodes,
determined
claims-based
algorithms
alcohol-specific
diagnosis
codes.
The
secondary
outcome
was
subset
episodes
due
disease.
Results
Rates
statistically
higher
than
expected
4
18
(range
absolute
relative
increases:
0.4-0.8
per
100
000
8.3%-19.4%,
respectively).
Women
aged
40
64
experienced
significant
increases
10
1.3-2.1
33.3%-56.0%,
In
this
same
population,
above
16
0.8-2.1
34.1%-94.7%,
Conclusions
Relevance
a
national,
commercially
insured
beyond
what
months.
33.3%
56.0%
months,
pattern
associated
large
sustained
complications.
Findings
underscore
need
for
attention
use
disorder
risk
factors,
patterns,
health
effects,
regulations
policies,
women
years.
Scientific Reports,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: Feb. 1, 2024
In
recent
years,
there
has
been
a
global
trend
of
aging,
which
resulted
in
significant
changes
to
the
burden
gastritis
and
duodenitis
(GD).
Using
disease
(GBD)
database
spanning
1990
2019,
we
evaluated
temporal
trends
age-standardized
incidence
rates
(ASIR),
death
(ASDR),
disability-adjusted
life
years
(AS-DALYs)
for
GD
using
estimated
annual
percentage
(EAPC).
Additionally,
examined
across
various
strata,
including
social
demographic
index
(SDI),
age,
sex.
Finally,
risk
factors
linked
mortality
GD,
utilizing
Pearson
correlation
analysis.
were
31
million
patients
globally,
notable
increase
12
from
1990,
while
ASIR,
ASDR,
AS-DALYs
all
showed
decrease.
Correlation
analysis
negative
relationship
between
ASIR
SDI.
Factors
like
hand
hygiene
vitamin
A
deficiency
had
positive
correlations
with
ASDR
2019.
Over
past
thirty
increased
alongside
population
aging.
Future
efforts
should
focus
on
exploring
prevention
special
attention
elderly
low
SDI
regions.
Journal of Korean Medical Science,
Journal Year:
2024,
Volume and Issue:
39(46)
Published: Jan. 1, 2024
Liver
disease
causes
over
two
million
deaths
annually
worldwide,
comprising
approximately
4%
of
all
global
fatalities.
We
aimed
to
analyze
liver
disease-related
mortality
trends
from
1990
2021
using
the
World
Health
Organization
(WHO)
Mortality
Database
and
forecast
rates
up
2050.
NPP—Digital Psychiatry and Neuroscience,
Journal Year:
2025,
Volume and Issue:
3(1)
Published: Jan. 3, 2025
Abstract
Reinforcement
learning
studies
propose
that
decision-making
is
guided
by
a
tradeoff
between
computationally
cheaper
model-free
(habitual)
control
and
costly
model-based
(goal-directed)
control.
Greater
typically
used
under
highly
rewarding
conditions
to
minimize
risk
maximize
gain.
Although
prior
have
shown
impairments
in
sensitivity
reward
value
individuals
with
frequent
alcohol
use,
it
unclear
how
these
arbitrate
based
on
the
magnitude
of
incentives.
In
this
study,
81
(47
Alcohol
Users
34
Non-Users)
performed
modified
2-step
task
where
stakes
were
sometimes
high,
other
times
they
low.
Maximum
posteriori
fitting
dual-system
reinforcement-learning
model
was
assess
degree
control,
utility
for
low-
high-stakes
trials
separately.
As
expected,
Non-Users
showed
significantly
higher
compared
lower
conditions,
whereas
no
such
difference
two
observed
Users.
Additionally,
both
groups
less
risk-averse
conditions.
However,
condition.
Lastly,
greater
associated
risk-sensitive
approach
Taken
together,
results
suggest
may
impaired
metacontrol,
making
them
flexible
varying
monetary
rewards
more
prone
risky
decision-making,
especially
when
are
high.
American Journal of Preventive Cardiology,
Journal Year:
2025,
Volume and Issue:
21, P. 100947 - 100947
Published: Feb. 8, 2025
To
examine
the
associations
between
unhealthy
alcohol
use
and
risk
of
coronary
heart
disease
(CHD)
among
women
men
aged
18-65
years.
An
observational
study
in
an
integrated
healthcare
system
with
systematic
screening.
We
identified
432,265
primary
care
patients
years
who,
2014-2015,
reported
weekly
intake
levels.
Weekly
intake,
categorized
into
below
(≤14/week
men;
≤7/week
women)
above
limits
(≥15/week
≥
8/week
per
U.S.
guidelines,
heavy
episodic
drinking
(HED,
≥5/≥4
drinks
any
day
past
3
months
for
men/women,
respectively).
Main
outcome
was
CHD
during
4-year
follow-up,
based
on
inpatient
ICD
diagnoses
myocardial
infarction
CHD.
Cox
proportional
hazards
models
adjusted
age,
sex,
race/ethnicity,
body
mass
index,
physical
activity,
smoking,
hypertension,
diabetes,
hyperlipidemia.
The
cohort
comprised
44
%
women,
mean
age
(standard
deviation)
43.5
(±13.1).
associated
higher
prevalence
cardiovascular
factors,
a
26
%,
19
43
overall,
men-
women-specific
after
adjusting
these
factors
(hazard
ratio
[95
confidence
interval]
=
1.26[1.13
-1.40],
1.19[1.04-1.35]
1.43[1.20-1.71],
In
large,
real-world,
diverse
population
screening
program,
having
increased
young
middle-aged
women.
Increased
due
to
warrants
particular
awareness
interventions.
JAMA Network Open,
Journal Year:
2025,
Volume and Issue:
8(3), P. e250695 - e250695
Published: March 13, 2025
Importance
Evidence-based,
patient-centered
treatment
for
alcohol
use
disorder
(AUD)
can
include
pharmacotherapy
with
naltrexone,
acamprosate,
or
disulfiram;
however,
these
medications
are
rarely
used.
Medicaid
managed
care
plans
(MCPs)
manage
health
services
nearly
80%
of
enrollees
and
the
largest
payer
addiction
services.
Little
is
known
about
MCP
policies
AUD
medications.
Objectives
To
describe
MCPs’
coverage
management
disulfiram
examine
associations
plan
characteristics
state
medication
coverage.
Design,
Setting,
Participants
In
this
cross-sectional
study,
a
content
analysis
was
performed
2021
insurance
benefit
data
241
comprehensive
MCPs
in
states
using
care,
as
well
secondary
sources.
Data
were
analyzed
from
May
to
August
2024.
Main
Outcomes
Measures
MCP-reported
utilization
requirements
(eg,
prior
authorization,
quantity
limit
requirements)
disulfiram,
oral
injectable
naltrexone
together
each
separately.
Independent
variables
included
(profit
status,
market
share)
policy
environment
which
embedded
(Section
1115
substance
waiver,
state-defined
preferred
drug
list).
Regressions
examined
Results
2021,
217
(90.0%)
covered
at
least
1
AUD:
132
(54.7%)
203
(84.2%)
175
(72.6%)
152
(63.0%)
103
(42.7%)
all
4
Prior
authorization
limits
applied,
except
75
(42.8%)
imposed
requirements.
Conclusions
Relevance
This
study
suggests
that
efforts
expand
prescribing
may
be
limited
by
gaps
support
covering
without
applying
strategies.